Atbin Djamshidian

Exenatide and the treatment of patients with Parkinson’s disease

Icíar Avilés-Olmos, John Dickson, Zinovia Kefalopoulou et al. · Journal of Clinical Investigation · 2013 · 494 citations

Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease

Icíar Avilés-Olmos, John Dickson, Zinovia Kefalopoulou et al. · Journal of Parkinson s Disease · 2014 · 291 citations · Full text

Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours

Sean S. O’Sullivan, K. Wu, Marios Politis et al. · Brain · 2011 · 289 citations

Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort study

Verena Rass, Ronny Beer, Alois Josef Schiefecker et al. · European Journal of Neurology · 2021 · 176 citations · Full text

Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort study

Verena Rass, Ronny Beer, Alois Josef Schiefecker et al. · European Journal of Neurology · 2022 · 110 citations · Full text